Sort by
Refine Your Search
-
Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description → Apply before 09/09/2025 (DD/MM/YYYY) 23:59 (Brussels Time) → Faculty
-
Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description → Apply before 03/09/2025 (DD/MM/YYYY) 23:59 (Brussels Time
-
Deadline 9 Sep 2025 - 21:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 38 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
Laboratory of Integrative Metabolomics, an established research group with extensive experience in both experimental and computational metabolomics. The current focus of the computational branch of our
-
Requirements The Odysseus programme is open to two types of candidates: Type I: Researchers who are internationally recognized as pioneers in their field and who have an appointment of minimum 80
-
their specific disciplines while gaining practical knowledge across the various fields of knowledge of the network. This training program is supported by an excellent team of partners who are world leaders in
-
To stimulate and support the bottom-up cooperation between the ENLIGHT university communities, ENLIGHT launched a first set of calls for joint initiatives in April 2024. A second set of calls was launched in April 2025. Each call targets joint proposals for specific types of actions involving at...
-
Science Commission: Evaluation of the research programme. In addition to the full proposal, the Science commission will also see the referee reports and the feedback from the applicants. The commission
-
offering state-of-the-art study programmes grounded in research in a wide range of academic fields, Ghent University is a logical choice for its staff and students. For the Business Informatics research
-
What? The TBM programme provides funding for biomedical research that focuses on new therapies or diagnoses, which are already further on the path from discovery to clinical application and offer a